{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T20:40:20Z","timestamp":1789418420001,"version":"build-2803163510"},"reference-count":35,"publisher":"Pharmaceutical Society of Japan","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological &amp; Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2025,10,1]]},"DOI":"10.1248\/bpb.b24-00883","type":"journal-article","created":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:09:45Z","timestamp":1759270185000},"page":"1464-1471","source":"Crossref","is-referenced-by-count":2,"title":["Disruption of Tight Junctions in Intestinal Epithelial Cells by Toxic Advanced Glycation End-Products"],"prefix":"10.1248","volume":"48","author":[{"given":"Ryoma","family":"Takeda","sequence":"first","affiliation":[{"name":"Department of Clinical Pharmacy, Graduate School of Pharmaceutical Sciences, Nagoya City University, 3\u20131 Tanabe-dori, Mizuho-ku, Nagoya 467\u20138603, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eisei","family":"Hori","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, Graduate School of Pharmaceutical Sciences, Nagoya City University, 3\u20131 Tanabe-dori, Mizuho-ku, Nagoya 467\u20138603, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Misaki","family":"Natori","sequence":"additional","affiliation":[{"name":"Education and Research Center for Clinical Pharmacy, Faculty of Pharmaceutical Sciences, Nagoya City University, 3\u20131 Tanabe-dori, Mizuho-ku, Nagoya 467\u20138603, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Yamada","sequence":"additional","affiliation":[{"name":"Education and Research Center for Clinical Pharmacy, Faculty of Pharmaceutical Sciences, Nagoya City University, 3\u20131 Tanabe-dori, Mizuho-ku, Nagoya 467\u20138603, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadahiro","family":"Hashita","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, Graduate School of Pharmaceutical Sciences, Nagoya City University, 3\u20131 Tanabe-dori, Mizuho-ku, Nagoya 467\u20138603, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Iwao","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, Graduate School of Pharmaceutical Sciences, Nagoya City University, 3\u20131 Tanabe-dori, Mizuho-ku, Nagoya 467\u20138603, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiko","family":"Sakai-Sakasai","sequence":"additional","affiliation":[{"name":"Department of Advanced Medicine, Medical Research Institute, Kanazawa Medical University; 1\u20131 Daigaku, Uchinada-cho, Kahoku-gun, Ishikawa 920\u20130293, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayoshi","family":"Takeuchi","sequence":"additional","affiliation":[{"name":"Department of Advanced Medicine, Medical Research Institute, Kanazawa Medical University; 1\u20131 Daigaku, Uchinada-cho, Kahoku-gun, Ishikawa 920\u20130293, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamihide","family":"Matsunaga","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, Graduate School of Pharmaceutical Sciences, Nagoya City University, 3\u20131 Tanabe-dori, Mizuho-ku, Nagoya 467\u20138603, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"163","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Dmytriv TR, Storey KB, Lushchak VI. Intestinal barrier permeability: the influence of gut microbiota, nutrition, and exercise. <i>Front. Physiol.<\/i>, <b>15<\/b>, 1380713 (2024).","DOI":"10.3389\/fphys.2024.1380713"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Al-Sadi R, Engers J, Abdulqadir R. Talk about micromanaging! Role of microRNAs in intestinal barrier function. <i>Am. J. Physiol. Gastrointest. Liver Physiol.<\/i>, <b>319<\/b>, G170\u2013G174 (2020).","DOI":"10.1152\/ajpgi.00214.2020"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Twarda-Clapa A, Olczak A, Bialkowska AM, Koziolkiewicz M. Advanced glycation end-products (AGEs): formation, chemistry, classification, receptors, and diseases related to AGEs. <i>Cells<\/i>, <b>11<\/b>, 1312 (2022).","DOI":"10.3390\/cells11081312"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Nie C, Li Y, Qian H, Ying H, Wang L. Advanced glycation end products in food and their effects on intestinal tract. <i>Crit. Rev. Food Sci. Nutr.<\/i>, <b>62<\/b>, 3103\u20133115 (2022).","DOI":"10.1080\/10408398.2020.1863904"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Phuong-Nguyen K, McNeill BA, Aston-Mourney K, Rivera LR. Advanced glycation end-products and their effects on gut health. <i>Nutrients<\/i>, <b>15<\/b>, 405 (2023).","DOI":"10.3390\/nu15020405"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Snelson M, Lucut E, Coughlan MT. The role of AGE-RAGE signalling as a modulator of gut permeability in diabetes. <i>Int. J. Mol. Sci.<\/i>, <b>23<\/b>, 1766 (2022).","DOI":"10.3390\/ijms23031766"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Qu W, Yuan X, Zhao J, Zhang Y, Hu J, Wang J, Li J. Dietary advanced glycation end products modify gut microbial composition and partially increase colon permeability in rats. <i>Mol. Nutr. Food Res.<\/i>, <b>61<\/b>, 1700118 (2017).","DOI":"10.1002\/mnfr.201700118"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Lim JM, Yoo HJ, Lee KW. High molecular weight fucoidan restores intestinal integrity by regulating inflammation and tight junction loss induced by methylglyoxal-derived hydroimidazolone-1. <i>Mar. Drugs<\/i>, <b>20<\/b>, 580 (2022).","DOI":"10.3390\/md20090580"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Paparo L, Coppola S, Nocerino R, <i>et al<\/i>. How dietary advanced glycation end products could facilitate the occurrence of food allergy. <i>J. Allergy Clin. Immunol.<\/i>, <b>153<\/b>, 742\u2013758 (2024).","DOI":"10.1016\/j.jaci.2023.11.023"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Morresi C, Cianfruglia L, Sartini D, Cecati M, Fumarola S, Emanuelli M, Armeni T, Ferretti G, Bacchetti T. Effect of high glucose-induced oxidative stress on paraoxonase 2 expression and activity in Caco-2 cells. <i>Cells<\/i>, <b>8<\/b>, 1616 (2019).","DOI":"10.3390\/cells8121616"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Kato S, Itoh K, Ochiai M, Iwai A, Park Y, Hata S, Takeuchi K, Ito M, Imaki J, Miura S, Yakabi K, Kobayashi M. Increased pentosidine, an advanced glycation end-product, in urine and tissue reflects disease activity in inflammatory bowel diseases. <i>J. Gastroenterol. Hepatol.<\/i>, <b>23<\/b> <b>(<\/b>Suppl. 2<b>)<\/b>, S140\u2013S145 (2008).","DOI":"10.1111\/j.1440-1746.2008.05552.x"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Jansen FAC, Fogliano V, Rubert J, Hoppenbrouwers T. Dietary advanced glycation end products interacting with the intestinal epithelium: what do we really know? <i>Mol. Metab.<\/i>, <b>73<\/b>, 101734 (2023).","DOI":"10.1016\/j.molmet.2023.101734"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Cao C, Tang M, Zhao N, Dong S, Wu H. Effects of fish protein with glycation extent on gut microbiota and colonic barrier function in mice fed a high-fat diet. <i>J. Funct. Foods<\/i>, <b>85<\/b>, 3439\u20133451 (2021).","DOI":"10.1016\/j.jff.2021.104636"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Sakasai-Sakai A, Takata T, Takino J, Takeuchi M. Impact of intracellular glyceraldehyde-derived advanced glycation end-products on human hepatocyte cell death. <i>Sci. Rep.<\/i>, <b>7<\/b>, 14282 (2017).","DOI":"10.1038\/s41598-017-14711-3"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Takino J, Sato T, Kanetaka T, Okihara K, Nagamine K, Takeuchi M, Hori T. RasGRP2 inhibits glyceraldehyde-derived toxic advanced glycation end-products from inducing permeability in vascular endothelial cells. <i>Sci. Rep.<\/i>, <b>11<\/b>, 2959 (2021).","DOI":"10.1038\/s41598-021-82619-0"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Takata T, Sakasai-Sakai A, Takeuchi M. Intracellular toxic advanced glycation end-products may induce cell death and suppress cardiac fibroblasts. <i>Metabolites<\/i>, <b>12<\/b>, 615 (2022).","DOI":"10.3390\/metabo12070615"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Ooi H, Koriyama Y. Toxic advanced glycation end-products-dependent Alzheimer\u2019s disease-like alternation in the microtubule system. <i>Curr. Alzheimer Res.<\/i>, <b>20<\/b>, 677\u2013681 (2023).","DOI":"10.2174\/0115672050288723240213053342"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Takeuchi M, Makita Z, Bucala R, Suzuki T, Koike T, Kameda Y. Immunological evidence that non-carboxymethyllysine advanced glycation end-products are produced from short chain sugars and dicarbonyl compounds <i>in vivo<\/i>. <i>Mol. Med.<\/i>, <b>6<\/b>, 114\u2013125 (2000).","DOI":"10.1007\/BF03401779"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Sakasai-Sakai A, Takata T, Takeuchi M. Intracellular toxic advanced glycation end-products promote the production of reactive oxygen species in HepG2 cells. <i>Int. J. Mol. Sci.<\/i>, <b>21<\/b>, 4861 (2020).","DOI":"10.3390\/ijms21144861"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Shirai K, Qiu S, Minowa H, Hashita T, Iwao T, Matsunaga T. Air-liquid interface culture and modified culture medium promote the differentiation of human induced pluripotent stem cells into intestinal epithelial cells. <i>Drug Metab. Pharmacokinet.<\/i>, <b>55<\/b>, 100994 (2024).","DOI":"10.1016\/j.dmpk.2023.100994"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Takino J, Sato T, Nagamine K, Sakasai-Sakai A, Takeuchi M, Hori T. Suppression of hepatic stellate cell death by toxic advanced glycation end-products. <i>Biol. Pharm. Bull.<\/i>, <b>44<\/b>, 112\u2013117 (2021).","DOI":"10.1248\/bpb.b20-00708"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Kikuchi C, Sakasai-Sakai A, Okimura R, Tanaka H, Takata T, Takeuchi M, Matsunaga T. Accumulation of toxic advanced glycation end-products induces cytotoxicity and inflammation in hepatocyte-like cells differentiated from human induced pluripotent stem cells. <i>Biol. Pharm. Bull.<\/i>, <b>44<\/b>, 1399\u20131402 (2021).","DOI":"10.1248\/bpb.b21-00520"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Takata T, Sakasai-Sakai A, Takeuchi M. Intracellular toxic advanced glycation end-products in 1.4E7 cell line induce death with reduction of microtubule-associated protein 1 light chain 3 and p62. <i>Nutrients<\/i>, <b>14<\/b>, 332 (2022).","DOI":"10.3390\/nu14020332"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Horowitz A, Chanez-Paredes SD, Haest X, Turner JR. Paracellular permeability and tight junction regulation in gut health and disease. <i>Nat. Rev. Gastroenterol. Hepatol.<\/i>, <b>20<\/b>, 417\u2013432 (2023).","DOI":"10.1038\/s41575-023-00766-3"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Chen Y, Li Y, Li X, Fang Q, Li F, Chen S, Chen W. Indole-3-propionic acid alleviates intestinal epithelial cell injury <i>via<\/i> regulation of the TLR4\/NF-\u03baB pathway to improve intestinal barrier function. <i>Mol. Med. Rep.<\/i>, <b>30<\/b>, 189 (2024).","DOI":"10.3892\/mmr.2024.13313"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Guibourdenche M, Haug J, Chevalier N, Spatz M, Barbezier N, Gay-Qu\u00e9heillard J, Anton PM. Food contaminants effects on an <i>in vitro<\/i> model of human intestinal epithelium. <i>Toxics<\/i>, <b>9<\/b>, 135 (2021).","DOI":"10.3390\/toxics9060135"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Li Z, Zhao Z, Chen S, Wang X, Wang D, Nie X, Yao Y. Ge-Gen-Qin-Lian decoction alleviates the symptoms of type 2 diabetes mellitus with inflammatory bowel disease <i>via<\/i> regulating the AGE-RAGE pathway. <i>BMC Complement. Med. Ther.<\/i>, <b>24<\/b>, 225 (2024).","DOI":"10.1186\/s12906-024-04526-x"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Yuan JH, Xie QS, Chen GC, Huang CL, Yu T, Chen QK, Li JY. Impaired intestinal barrier function in type 2 diabetic patients measured by serum LPS, Zonulin, and IFABP. <i>J. Diabetes Complications<\/i>, <b>35<\/b>, 107766 (2021).","DOI":"10.1016\/j.jdiacomp.2020.107766"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Lechuga S, Braga-Neto MB, Naydenov NG, Rieder F, Ivanov AI. Understanding disruption of the gut barrier during inflammation: should we abandon traditional epithelial cell lines and switch to intestinal organoids? <i>Front. Immunol.<\/i>, <b>14<\/b>, 1108289 (2023).","DOI":"10.3389\/fimmu.2023.1108289"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Bigagli E, D\u2019Ambrosio M, Cinci L, Fiorindi C, Agostiniani S, Bruscoli E, Nannoni A, Lodovici M, Scaringi S, Giudici F, Luceri C. Impact of preoperative immunonutrition on oxidative stress and gut barrier function in surgical patients with Crohn\u2019s disease. <i>Nutrients<\/i>, <b>15<\/b>, 882 (2023).","DOI":"10.3390\/nu15040882"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Takata T, Sakasai-Sakai A, Takino J, Takeuchi M. Evidence for toxic advanced glycation end-products generated in the normal rat liver. <i>Nutrients<\/i>, <b>11<\/b>, 1612 (2019).","DOI":"10.3390\/nu11071612"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Yamagishi S, Nakamura K, Matsui T, Inagaki Y, Takenaka K, Jinnouchi Y, Yoshida Y, Matsuura T, Narama I, Motomiya Y, Takeuchi M, Inoue H, Yoshimura A, Bucala R, Imaizumi T. Pigment epithelium-derived factor inhibits advanced glycation end product-induced retinal vascular hyperpermeability by blocking reactive oxygen species-mediated vascular endothelial growth factor expression. <i>J. Biol. Chem.<\/i>, <b>281<\/b>, 20213\u201320220 (2006).","DOI":"10.1074\/jbc.M602110200"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Zhang Y, Yang X, Qiu C, Liu F, Liu P, Liu Z. Matrine suppresses AGE-induced HAEC injury by inhibiting ROS-mediated NRLP3 inflammasome activation. <i>Eur. J. Pharmacol.<\/i>, <b>822<\/b>, 207\u2013211 (2018).","DOI":"10.1016\/j.ejphar.2018.01.029"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Takeuchi M. Toxic AGEs (TAGE) cause lifestyle-related diseases. <i>Antioxidants<\/i>, <b>13<\/b>, 1372 (2024).","DOI":"10.3390\/antiox13111372"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Morgan MJ, Kim YS, Liu ZG. TNF\u03b1 and reactive oxygen species in necrotic cell death. <i>Cell Res.<\/i>, <b>18<\/b>, 343\u2013349 (2008).","DOI":"10.1038\/cr.2008.31"}],"container-title":["Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/48\/10\/48_b24-00883\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T03:43:04Z","timestamp":1759549384000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/48\/10\/48_b24-00883\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,1]]},"references-count":35,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b24-00883","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,1]]},"article-number":"b24-00883"}}